Abstract: Described herein relates to a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Described herein relates to a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: The present disclosure pertains to an anhydrous topical composition for retarding and/or inhibiting scarring of a wound, burn and/or skin condition located on the skin of a subject. Additionally, the topical composition may comprise the following: MCT, monolaurin, cetyl esters, marine oil, vegetable oil having an omega 3 fatty acid content greater than 9 wt %, and/or rice bran wax.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: Disclosed herein relates to compositions of and methods for the treatment of skin damage and/or wounds, while simultaneously relieving pain and/or cosmetic damage. As such, the present disclosure relates to an anhydrous topical composition for retarding and/or inhibiting scarring of a wound, burn and/or skin condition located on the skin of a subject while retaining a natural characteristic and/or elasticity of the skin. The anhydrous topical composition may comprise MCT, monolaurin, cetyl esters, marine oil, vegetable oil having an omega 3 fatty acid content greater than 9 wt %, and/or hempseed oil. Additionally, the anhydrous topical composition may comprise antimicrobial properties and/or characteristics, such that the anhydrous topical composition may be configured to inhibit any pathogen (e.g., a bacteria, a virus, a fungus, etc.) within the wound, burn and/or skin condition, when applied to the skin of the subject.

Abstract: Disclosed is a topical anhydrous, homogenous pharmaceutical composition for treating skin disorder and wounds comprising cod liver oil, hempseed oil, monolaurin, medium chain triglycerides (“MCT”), free fatty acids, sea salt, and vegetable oil selected from the group consisting of red palm concentrate, coconut oil, and red palm oil and combination thereof and optionally fish collagen, ascorbyl palmitate, thickening agent, such as beeswax, red palm concentrate and cetyl ester.

Abstract: In one embodiment, hydrodynamic cavitation lyses influent bacteria, releasing intracellular enzymes, and creates CaCO3 seed crystals that are discharged at the base of the water column. Bottom-dwelling upflow anaerobic sludge blanket (UASB)-like granules grow in a dense, viscous N, P & Ca++ rich fluid (“hydrolytic brine”). The brine hydrolyzes ancient sludge and fresh solids into simple liquids. The granules convert hydrolyzed liquids into gas. New CaCO3 seeds grow at the produced gas/supernatant interface and propagate across the entire lagoon. Once the sludge inventory is digested, there is an excess of granules that modulate their gross productivity in response to substrate load, pH, and temperature. In one specific example, the treated lagoon has no odor, is free of gelled sludge and effluent.

Abstract: The present invention relates to a topical pharmaceutical composition comprising povidone-iodine, a tertiary amide, surfactant and coconut oil, useful for killing microbes and treating wounds or sores on the surface of the skin.

Abstract: In one embodiment, a method of reducing at least one of nitrogen, carbon and phosphorous in a lagoon that includes at least three cells.

Abstract: Disclosed is a method of reducing the rancid fish odor smell in a topical composition comprised of fish oil which comprises mixing the composition with monolaurin. Also disclosed are various anhydrous topical compositions comprising fish oil. One comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, and monolaurin, another one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin, collagen and sea salt, an a third one comprises fish oil, cetyl ester, palm olein, medium-chain triglyceride(s) of a mixture of C8 and C10 fatty acids, mixture of C8/C10 fatty acids, monolaurin and hydrocolloid. These compositions are useful for treating wounds and skin conditions.

Abstract: The present invention relates to a topical pharmaceutical composition comprising povidone-iodine, a tertiary amide, surfactant and coconut oil, useful for killing microbes and treating wounds or sores on the surface of the skin.

Abstract: Systems and methods for treatment of wastewater in waste processing ponds and other enclosed bodies of water are provided. An aerator are configured to include a first set of concentric air hoses disposed at a first position between the water outflow lip and the water intake, the first set of concentric air hoses being in fluid communication with an air inlet disposed at a position on the upper float chassis above the surface level of the water; and a second set of concentric air hoses disposed at a second position between the water first set of concentric air hoses and the water intake, the second set of concentric air hoses being in fluid communication with the air inlet, wherein the first set of concentric air hoses and the second set of concentric air hoses emit jets of air bubbles into the water column between the water intake and the water outflow lip.

Abstract: The present invention relates to a topical pharmaceutical composition comprising povidone-iodine, a tertiary amide, surfactant and coconut oil, useful for killing microbes and treating wounds or sores on the surface of the skin.

Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.

Abstract: Systems and methods for treatment of wastewater in waste processing ponds and other enclosed bodies of water are provided. An aerator are configured to include a first set of concentric air hoses disposed at a first position between the water outflow lip and the water intake, the first set of concentric air hoses being in fluid communication with an air inlet disposed at a position on the upper float chassis above the surface level of the water; and a second set of concentric air hoses disposed at a second position between the water first set of concentric air hoses and the water intake, the second set of concentric air hoses being in fluid communication with the air inlet, wherein the first set of concentric air hoses and the second set of concentric air hoses emit jets of air bubbles into the water column between the water intake and the water outflow lip.

Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.

Abstract: The present invention relates to an apparatus for the treatment of contaminated air or surfaces in order to remove or oxidize odoriferous gases and deleterious compounds therefrom through the utilization of ozone droplets, and more particularly pertains to the treatment of manufacturing facilities, wet wells, seage installations, buildings, equipment and industrial installations and diverse locales subjected to foul air, in order to remove noxious and potentially toxic vapors and impurities from the air or surfaces through the dissolution of ozone in water to form droplets, and spraying the resultant mixture into the air as a fine aqueous mist. Moreover, the invention is also directed to the provision of a process for eliminating odoriferous or noxious vapor gases and harmful constituents entrained therein from a volume of contaminated air or surfaces through the utilization of ozone dissolved in water by the employment of the inventive treatment apparatus.

Abstract: A system and method reducing pollution in a body of water using biological processes is provided. The system includes a hydraulic dam generated by an induced downwelling of effluent water from a plurality of water circulating devices. A series of linearly arranged treatment sub-systems are disposed upstream of the hydraulic dam. The treatment sub-systems include a water sterilization sub-system for neutralizing harmful and undesirable micro-organisms using an ultrasonic energy generating unit. The ultrasonic energy generated, is of a frequency that disrupts cellular structures in targeted micro-organisms.

Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.